TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Ebba Biotech AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,875
|
1,407
|
1,133 |
Financial expenses |
20
|
15
|
22 |
Earnings before taxes |
-1,828
|
-3,215
|
-2,696 |
EBITDA |
-1,746
|
-3,147
|
-2,615 |
Total assets |
1,240
|
1,700
|
1,490 |
Current assets |
1,091
|
1,530
|
1,255 |
Current liabilities |
447
|
766
|
236 |
Equity capital |
287
|
555
|
474 |
- share capital |
64
|
60
|
61 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
23.1%
|
32.6%
|
31.8% |
Turnover per employee |
469
|
352
|
378 |
Profit as a percentage of turnover |
-97.5%
|
-228.5%
|
-238.0% |
Return on assets (ROA) |
-145.8%
|
-188.2%
|
-179.5% |
Current ratio |
244.1%
|
199.7%
|
531.8% |
Return on equity (ROE) |
-636.9%
|
-579.3%
|
-568.8% |
Change turnover |
369
|
307
|
591 |
Change turnover % |
24%
|
28%
|
109% |
Chg. No. of employees |
0
|
1
|
2 |
Chg. No. of employees % |
0%
|
33%
|
200% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.